H-GLY-PRO-GLY-NH2 HCL
- CAS No.
- 141497-12-3
- Chemical Name:
- H-GLY-PRO-GLY-NH2 HCL
- Synonyms
- GPG-NH2;H-Gly-Pro-Gly-NH2;H-GLY-PRO-GLY-NH2 HCL;Glycyl-L-prolylglycinamide;Glycinamide, glycyl-L-prolyl-;H-Gly-Pro-Gly-NH2 hydrochloride
- CBNumber:
- CB1483048
- Molecular Formula:
- C9H16N4O3
- Molecular Weight:
- 228.25
- MDL Number:
- MFCD30294771
- MOL File:
- 141497-12-3.mol
- TDS File:
- TDS
| Product description | Number | Pack Size | Price |
| H-Gly-Pro-Gly-NH2·HCl | FG110459 | 100mg | $900 |
| H-Gly-Pro-Gly-NH2·HCl | FG110459 | 25mg | $900 |
| H-Gly-Pro-Gly-NH2·HCl | FG110459 | 250mg | $900 |
| H-Gly-Pro-Gly-NH2·HCl | FG110459 | 50mg | $900 |
| H-Gly-Pro-Gly-NH2·HCl | FG110459 | 500mg | $1255 |
| Boiling point | 618.0±55.0 °C(Predicted) |
|---|---|
| Density | 1.326±0.06 g/cm3(Predicted) |
| storage temp. | -15°C |
| pka | 14.27±0.20(Predicted) |
| Sequence | H-Gly-Pro-Gly-NH2 · HCl |
| FDA UNII | 73GV270Z6Z |
H-GLY-PRO-GLY-NH2 HCL price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Biosynth | FG110459 | H-Gly-Pro-Gly-NH2·HCl | 141497-12-3 | 100mg | $900 | 2026-06-04 | Buy |
| Biosynth | FG110459 | H-Gly-Pro-Gly-NH2·HCl | 141497-12-3 | 25mg | $900 | 2026-06-04 | Buy |
| Biosynth | FG110459 | H-Gly-Pro-Gly-NH2·HCl | 141497-12-3 | 250mg | $900 | 2026-06-04 | Buy |
| Biosynth | FG110459 | H-Gly-Pro-Gly-NH2·HCl | 141497-12-3 | 50mg | $900 | 2026-06-04 | Buy |
| Biosynth | FG110459 | H-Gly-Pro-Gly-NH2·HCl | 141497-12-3 | 500mg | $1255 | 2026-06-04 | Buy |
H-GLY-PRO-GLY-NH2 HCL Chemical Properties,Uses,Production
Uses
H-Gly-Pro-Gly-NH2 is a tripeptide that inhibits HIV-1 replication. H-Gly-Pro-Gly-NH2 inhibits the activity of HIV-1 IIIB and HIV-2 ROD with EC50 values of 35 μM and 30 μM, respectively. H-Gly Pro Gly NH2 inhibits HIV-1 replication in vitro by interfering with capsid formation. H-Gly Pro Gly NH2 has antiviral activity and can be used for virus research[1][2][3].
IC 50
HIV (IIIB): 35 μM (EC50); HIV-2 (ROD): 30 μM (EC50)
References
[1] Hglund S, et al. Tripeptide interference with human immunodeficiency virus type 1 morphogenesis. Antimicrob Agents Chemother. 2002 Nov;46(11):3597-605. DOI:10.1128/AAC.46.11.3597-3605.2002
[2] Andersson E, et al. No cross-resistance or selection of HIV-1 resistant mutants in vitro to the antiretroviral tripeptide glycyl-prolyl-glycine-amide[J]. Antiviral research, 2004, 61(2): 119-124.
[3] Balzarini J, et al. Obligatory involvement of CD26/dipeptidyl peptidase IV in the activation of the antiretroviral tripeptide glycylprolylglycinamide (GPG-NH(2)). Int J Biochem Cell Biol. 2004 Sep;36(9):1848-59. DOI:10.1016/j.biocel.2004.02.017
H-GLY-PRO-GLY-NH2 HCL Preparation Products And Raw materials
Raw materials
Preparation Products
H-GLY-PRO-GLY-NH2 HCL Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Shenzhen Nexconn Pharmatechs Ltd | +86-755-89396905 +86-15013857715 | admin@nexconn.com | China | 10399 | 58 |
| Nextpeptide Inc | +86-0571-81612335 +8613336028439 | sales@nextpeptide.com | China | 19905 | 58 |
| Chengdu Youngshe Chemical Co., Ltd. | +86-18108235634 | Cecilia@youngshechem.com | China | 2345 | 58 |
| Nanjing TGpeptide | +86-13347807150 | support@tgpeptide.com | China | 3279 | 58 |
| LEON (NANJING) BIOTECHNOLOGY CO., LTD. | 15051830413 | sales.njleonbiotech@gmail.com | China | 5482 | 58 |
| GL Biochem (Shanghai) Ltd | 21-61263452 13641803416 | ymbetter@glbiochem.com | China | 9981 | 64 |
| Shanghai Hanhong Scientific Co.,Ltd. | 021-54306202 13764082696 | info@hanhongsci.com | China | 42917 | 64 |
| Chemsky (shanghai) International Co.,Ltd | 021-50135380 | shchemsky@sina.com | China | 15350 | 60 |
| Shanghai Chaolan Chemical Technology Center | QQ：65489617 13301690235 | Sales@ATKchemical.com | China | 9647 | 58 |
| Nanjing Leon Biological Technology Co., Ltd. | 025-84523390 -127; 17705183659 | sales@njleonbiotech.com | China | 5501 | 55 |
141497-12-3(H-GLY-PRO-GLY-NH2 HCL)Related Search:
1of4
